medigraphic.com
SPANISH

Revista Mexicana de Cardiología

ISSN 0188-2198 (Print)
En 2019, la Revista Mexicana de Cardiología cambió a Cardiovascular and Metabolic Science

Ver Cardiovascular and Metabolic Science


  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2010, Number 2

<< Back Next >>

Rev Mex Cardiol 2010; 21 (2)

Results of the first 5 patients with iliac artery lesions treated by placement of a platinum/iridium stent of mexican manufacture and literature review

Abundes VA, Arizmendi UE, Odin DRM, Estrada GJ, Quintana PG
Full text How to cite this article

Language: English
References: 28
Page: 49-56
PDF size: 210.82 Kb.


Key words:

Platinum/iridium stent, iliac artery lesions, angiographic success.

ABSTRACT

Introduction: This article submits the results of the first five patients treated with a platinum stent designed and manufactured in Mexico by our working group. The stent has gold welded joints and it may be mounted on peripheral angioplasty conventional balloons. Material and methods: We submit a case and control report of four patients treated at the Cardiology Hospital of the National Medical Center (CMN) of the Mexican Social Security Institute (IMSS), and of one patient that was studied and treated at the Hospital General de Salubridad (General Health Hospital) of Culiacán, State of Sinaloa. All patients underwent the implantation of a platinum stent in six iliac segments. The stents used were 30 mm long and between 6 and 8 mm in diameter. Results: All treated patients exhibited angiographic and clinical success during hospitalization with no complications and blockage opening. Conclusions: The platinum stent manufactured in Mexico could become an efficient alternative to those currently available.


REFERENCES

  1. CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329-1339.

  2. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA and F.G.R. Fowkes on behalf of the TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007; 45(1): S5A-S67A.

  3. Abundes VA, Quintana G, Navarro RJ et al. Experimentación con un stent de platino fabricado en México (Experimenting with a platinum stent manufactured in Mexico). In: García MC, Reyes MH, Viniegra VI, publishers. Las múltiples facetas en investigación en salud, proyectos estratégicos del Instituto Mexicano del Seguro Social (The multiple aspects of health research, strategic projects of the Mexican Social Security Institution). Mexico City. Sesante SA de CV publishers. 2001: 71-90.

  4. Abundes VA, Arizmendi E, Montoya S et al. Resultados inmediatos y a largo plazo del implante de un nuevo stent coronario de platino (stent Atlas) en pacientes con enfermedad arterial coronaria (Immediate and long-term results after placement of the new coronary platinum stent (Atlas stent) in patients with coronary arterial disease). Rev Esp Cardiol 2002; 55: 1205-1208.

  5. Rutherford, RB, Baker JD, Ernst C et al. Recommended standards for reports dealing with lower extremity ischemia. Journal of Vascular Surgery 1997: 26(3): 517-538

  6. Hijazi ZM, Homoud M, Aronvitz MJ, Smith JJ, Faller GT. A new platinum balloon-expandable stent (Angiostent) mounted on high pressure balloon: Acute and late results in atherogenic swin model. J Invasive Cardiol 1995; 7: 127-134.

  7. Criqui M, Fronek A, Klauber M et al. The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from noninvasive testing in a defined population. Circulation 1985; 71(3): 516-522.

  8. McDermott, McGrae M, Liu, Kiang et al. The Ankle Brachial Index Independently Predicts Walking Velocity and Walking Endurance in Peripheral Arterial Disease. J Am Ger Soc Volume 1998; 46: 1355-1362.

  9. Weitz JI, Chair BJ, Clagett GP et al. AHA Scientifc Statement: Diagnosis and Treatment Chronic Arterial Insufficiency of the Lower Extremities: A Critical Review. Circulation 1996; 94: 3026-3049.

  10. Hamer OW, Borisch I, Finkenzeller T et al. Iliac Artery Stent Placement: Clinical Experience and Short-term Regarding a Self-expanding Nitinol Stent. Journal of Vascular and Interventional Radiology 2004; 15: 1231-1238.

  11. Gaines PA, Schulte KL, Müller-Hu S et al. A Multicentre Evaluation of the Medtronic AVE Flexible Iliac Bridge Stent in the Iliac Arteries (the First Study). Eur J Vasc Endovasc Surg 2005; 29: 124-130.

  12. Ponec D, Jaff MR, Swischuk J et al. The Nitinol SMART Stent vs. Wallstent for Suboptimal Iliac Artery Angioplasty: CRISP-US Trial Results. J Vasc Interv Radiol 2004; 15: 911-918.

  13. Lau and Cheng. Angioplasty and Stenting of Iliac Artery. J Am Coll Surg 1998; 186: 408-414.

  14. Powell RJ, Fillinger M, Bettmann M, Jeffery R et al. The durability of endovascular treatment of multisegment iliac occlusive disease. J Vasc Surg 2000; 31: 1178-1184.

  15. Derom FA, Vermassen, Ongena K. PTA and Stenting after Previous Aortoiliac Endarterectomy. Eur J Vasc Endovasc Surg 2001; 22: 130-133.

  16. Uberoi R, Sarker JB. Coleman A et al. Duplex Follow-up of Aorto-iliac Stents. Eur J Vasc Endovasc Surg 2002; 23: 331-335.

  17. Smet AE, Tetteroo E, Moll FL et al. Noninvasive evaluation before and after percutaneous therapy of iliac artery stenoses: The value of the Bernoulli predicted pressure gradient for the Dutch Iliac Stent Trial Study Group. J Vasc Surg 2000; 32: 153-159.

  18. Timaran CH, Stevens SL, Freeman et al. Tenn. External iliac and common iliac artery angioplasty and stenting in men and women. J Vasc Surg 2001; 34: 440-446.

  19. Lee ES, Coleman C, Trimble KE et al. Minneapolis, Minn Comparing patency rates between external iliac and common iliac artery stents. J Vasc Surg 2000; 31: 889-894.

  20. Timaran CH, Stevens SL, Freeman MB et al. Predictors for adverse outcome after iliac angioplasty and stenting for limb-threatening. Ischemia. J Vasc Surg 2002; 36: 507-513.

  21. Timaran CH, Ohki T, Gargiulo NJ et al. Iliac artery stenting in patients with poor distal runoff: Influence of concomitant infrainguinal arterial reconstruction. J Vasc Surg 2003; 38: 479-485.

  22. Nawaz TS, Gaines CP, Beard J et al. Aortoiliac Stenting, Determinants of Clinical Outcome. Eur J Vasc Endovasc Surg 1999; 17: 351-359.

  23. Reekers JA, Vorwerk D, Rousseau H et al. Results of a European Multicentre Iliac Stent Trial with a Flexible Balloon Expandable Stent. Eur J Vasc Endovasc Surg 2002; 24: 511-515.

  24. Scheinert D, Schröder M, Ludwig J et al. Stent-supported Recanalization of Chronic Iliac Artery Occlusions. Am J Med 2001; 110: 708-715.

  25. Timaran CH, Prault TL, Stevens SL et al. Iliac artery stenting versus surgical reconstruction for TASC (TransAtlantic Inter-Society Consensus) type B and type C iliac lesions. J Vasc Surg 2003; 38: 272-278.

  26. Greiner A, Dessl A, Klein-Weigel P. Kissing Stents for Treatment of Complex Aortoiliac Disease. Eur J Vasc Endovasc Surg 2003; 26: 161-165.

  27. Buckley CJ, Arko FR, Lee S et at. Intravascular ultrasound scanning improves long-term patency of iliac lesions treated with balloon angioplasty and primary stenting. J Vasc Surg 2002; 35: 316-323.

  28. Bosch JL, Haaring C, Meyerovitz MF et al. Cost-Effectiveness of Percutaneous Treatment of Iliac Artery Occlusive Disease in the United States. AJR 2000; 175: 517-521.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Cardiol. 2010;21